GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
51.02
-1.35 (-2.58%)
At close: Nov 16, 2026, 4:00 PM EST
51.51
+0.49 (0.96%)
After-hours: Nov 16, 2026, 7:47 PM EST

GeneDx Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
460.78427.54305.45202.57234.69212.2
Revenue Growth
14.57%39.97%50.79%-13.69%10.60%18.33%
Gross Profit
316.85298.18194.4590.15-26.75-16.6
Operating Income
-63.06-11.67-23.16-170.06-457.51-446.15
Net Income
-111.05-21.02-52.29-175.77-548.98-245.39
Earnings Per Share
-3.76-0.73-1.94-7.23-53.63-74.93
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
GeneDx
456.33423.09302.29194.38122.23-
Legacy Sema4
--3.168.19112.46212.2
Fabric Genomics and Legacy Sema4
-4.45----
Total
460.78427.54305.45202.57234.69212.2

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
170.12171.28141.19130.15123.93400.57
Total Debt
215.38113.17117.38119.2777.1311
Net Cash (Debt)
-45.2758.1123.8110.8846.8389.57
Net Cash Growth
-144.11%118.91%-76.76%-87.99%517.31%
Net Cash Per Share
-1.532.030.890.454.57118.95

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-75.0833.28-28.5-180.15-319.16-190.43
Capital Expenditures
-26.14-19.02-5.49-5.25-7.16-9.4
Free Cash Flow
-101.2214.26-33.99-185.4-326.31-199.83
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
68.76%69.74%63.66%44.50%-11.40%-7.82%
Operating Margin
-13.68%-2.73%-7.58%-83.95%-194.94%-210.25%
Pretax Margin
-24.13%-4.94%-17.23%-87.23%-254.81%-115.64%
Profit Margin
-24.10%-4.92%-17.12%-86.77%-233.91%-115.64%
FCF Margin
-21.97%3.34%-11.13%-91.52%-139.04%-94.17%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
53.25250.14190.96---
P/FCF Ratio
-263.59----
PS Ratio
3.328.796.910.350.445.07